Why the study?
What is the population seroprevalence of poliovirus types 1, 2, and 3 among children 6-59 months old in the DRC, and what is the impact of mass immunization campaigns?
What is the population seroprevalence of poliovirus types 1, 2, and 3 among children 6-59 months old in the DRC, and what is the impact of mass immunization campaigns?
Overall polio immunity was high in the DRC, but supplementary immunization campaigns and routine immunization remain critical to address pockets of low immunity.
No takes yet. Share an insight, caveat, or question.
Signals outbreak risk from immunity gaps in DRC; leaves open optimal strategies to sustain seroprevalence.
Voorman et al. (2017) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: